Indeed, melanoma patients treated with a pDC-based cellular vaccine displayed an IFN signature, which even was detected in patients receiving the lowest dose cells, indicating that stimulated human pDCs are highly potent also in vivo [4]. Here, IFNA1 is linked to melanoma.